COMMUNIQUÉS West-GlobeNewswire

VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent regarding Methods of Production for AV-101

02/05/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN ), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]

Hemispherx Provides an Update to Stockholders Highlighting Cancer Focus and $10 Million Booked Since Start of Year Will Support Increased Production of Ampligen for Immuno-Oncology Clinical Trials

02/05/2018 - 14:30

ORLANDO, Fla., May 02, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) would like to share a letter with its stockholders today, highlighting 2017 results, recent achievements, and outlining [...]

Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018

02/05/2018 - 14:30

LONDON, May 02, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Trading by management and close relations of management

02/05/2018 - 14:13

Read the full announcement in the attached file Attachment 2018_23_Trading_by_management_EN

Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 2018

02/05/2018 - 14:03

CORAL GABLES, Fla., May 02, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in May

02/05/2018 - 14:01

SAN CARLOS, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Endocyte Announces First Quarter 2018 Earnings Call

02/05/2018 - 14:01

WEST LAFAYETTE, Ind., May 02, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company [...]

Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference

02/05/2018 - 14:00

DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. Michelle [...]

Selecta Biosciences Announces Date of First Quarter 2018 Financial Results Conference Call

02/05/2018 - 14:00

WATERTOWN, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer

02/05/2018 - 14:00

WALTHAM, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced the appointment of J. Alan Butcher as executive vice president and chief business officer effective immediately [...]

Jounce Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018

02/05/2018 - 14:00

CAMBRIDGE, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Cellectar Receives Rare Pediatric Disease Designation for CLR 131 to Treat Neuroblastoma

02/05/2018 - 14:00

MADISON, Wis., May 02, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]

Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow

02/05/2018 - 14:00

TORONTO, May 02, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the precision of real-time MR [...]

Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018

02/05/2018 - 14:00

MORRIS PLAINS, N.J., May 02, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that it will host a conference call on Wednesday, May 9, 2018 at 5:00 p.m. [...]

Cellaria Forms Collaborative Partnership with SBH Sciences

02/05/2018 - 14:00

Combines SBH’s assay services with Cellaria’s patient-specific cell models and cell culture media products Cambridge, Mass. and Natick, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Cellaria, LLC , a scientific innovator that [...]

Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S.

02/05/2018 - 14:00

MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Reality television personality Cameran Eubanks and Dermira, Inc. (NASDAQ: DERM ) announced today that they are collaborating on a new educational campaign aimed at [...]

aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting

02/05/2018 - 14:00

– Identification of T Cell Immunomodulatory Domain in Resokine – SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of [...]

Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis

02/05/2018 - 14:00

Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical company with a core focus [...]

Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10

02/05/2018 - 13:57

BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), today announced that management will host a conference call and webcast slide presentation on Thursday, May 10, at 4:30 p.m. ET to [...]